Literature DB >> 14517805

18-fluorodeoxyglucose positron emission tomography in nonendocrine neoplastic disorders of the gastrointestinal tract.

Allessio Annovazzi1, Marc Peeters, Annelies Maenhout, Alberto Signore, Rudi Dierckx, Christophe Van De Wiele.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14517805     DOI： 10.1016/s0016-5085(03)01208-3

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  3 in total

1.  Impact of 18-fluorodeoxyglucose positron emission tomography on the management of pancreatic cancer.

Authors:  Kunihiko Izuishi; Yuka Yamamoto; Takanori Sano; Ryusuke Takebayashi; Tsutomu Masaki; Yasuyuki Suzuki
Journal:  J Gastrointest Surg       Date:  2010-05-05       Impact factor: 3.452

2.  Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness.

Authors:  Stefan Heinrich; Gerhard W Goerres; Markus Schäfer; Markus Sagmeister; Peter Bauerfeind; Bernhard C Pestalozzi; Thomas F Hany; Gustav K von Schulthess; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2005-08       Impact factor: 12.969

Review 3.  Vascular invasion in pancreatic cancer: Imaging modalities, preoperative diagnosis and surgical management.

Authors:  Nicolas C Buchs; Michael Chilcott; Pierre-Alexandre Poletti; Leo H Buhler; Philippe Morel
Journal:  World J Gastroenterol       Date:  2010-02-21       Impact factor: 5.742
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.